M-10 (Medical University of South Carolina)

N/A

Report date: 2025/03/20 16:09:01

Base Information

Drug NameM-10 (Medical University of South Carolina)
Drug Alias NameM-10
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMothers against decapentaplegic homolog 2 modulatorsTransforming growth factor beta 1 modulators
TargetsMothers against decapentaplegic homolog 2Transforming growth factor beta 1
Therapy Area/IndicationsScleroderma-associated interstitial lung diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesN/A
Active IndicationsScleroderma-associated interstitial lung diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A